Patents
Patents for C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids (54,756)
11/2000
11/15/2000EP1051385A1 Processes for preparing oxygenates and catalysts therefor
11/15/2000EP1051382A1 Oligomeric halogenated diphenyl ether compounds
11/15/2000EP1051165A2 Mitochondria protecting agents for treating mitochondria associated diseases
11/15/2000EP0799246B1 Improved mutable composition
11/15/2000CN1273578A Method for cleaning system components
11/15/2000CN1273540A Basic catalysts and process for producing carbonyl compound derivatives
11/15/2000CN1273234A Method for preparing substituted 3-hydroxybutyrate
11/15/2000CN1273136A Method for avoiding polymerization generation in film-type evaporator
11/15/2000CN1058485C Process for working up the liquid reaction products from Cu-catalysted preparation of dimethyl carbonate
11/15/2000CN1058484C Process for preparation of dialkyl carbonates
11/15/2000CN1058483C Proessing for preparing aryl carbonates
11/15/2000CN1058482C Process for preparing aryl carbonates
11/15/2000CN1058481C Process for production of aryl carbonates
11/15/2000CN1058480C Catalysts and processes for the manufacture of vinyl acetate
11/14/2000US6147255 Topical and systemic treatment of dermatological complaints associated with keratinization disorder which has effect on differentiation and on proliferation
11/14/2000US6147252 Ester interchange between alkyl ester of methacrylic or acrylic acid and alcohol in presence of catalyst by continuously conducting said reaction in continuous multistage distillation column while distilling off by-product alcohol
11/14/2000US6147251 Preparation of derivatives of halo-but-2-enoic acids and esters high in 2-ene content; catalyst promoters in ethylene polymerization and copolymerization
11/14/2000US6147249 Ester compound capable of forming acid-decomposable polymer which can be blended as base resin to formulate resist composition having higher sensitivity, resolution and etching resistance than conventional resist compositions
11/14/2000US6147246 Reacting alkylene oxide with dialkyl carbonate in presence of catalytically effective amount of calcium-containing catalyst
11/14/2000US6147231 Process for producing 2(2-hydroxymethylphenyl)acetamide derivative and intermediate for the production thereof
11/14/2000US6147224 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/14/2000US6147217 Synthesis of terfenadine and derivatives
11/14/2000US6147216 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/14/2000US6147037 Fragrance delivery systems
11/14/2000CA2080221C An improved process for the preparation of substituted indolone derivatives
11/14/2000CA1341138C Fluorine-containing chiral smectic liquid crystals
11/09/2000WO2000066536A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066535A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066534A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066533A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066532A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066531A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066530A1 Method and catalyst system for producing aromatic carbonates
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066524A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066261A1 Catalyst and method for producing vinyl acetate
11/09/2000WO2000066111A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000DE19920147A1 Minz- und/oder Fruchtaromakompositionen Mint and / or fruit flavoring compositions
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372672A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/08/2000EP1050574A2 Mint and/or fruit flavour compositions
11/08/2000EP1049759A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
11/08/2000EP1049684A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049659A1 Fluorinated oxyvinyl compounds and methods of preparing and using same
11/08/2000EP1049537A2 Catalytic compositions and methods for asymmetric allylic alkylation
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000EP0794991B1 Cholesteric polymer network
11/08/2000CN1272836A (Poly) alkylene glycol higher-alkyl ether derivative composition, and detergent, lubricant, and external-use skin preparation each containing the same
11/08/2000CN1058257C Process for production of cyclohexyl adipates
11/07/2000US6143935 Process for the preparation of 1,3-dicarbonyl compounds
11/07/2000US6143922 Diols and unsaturated monomers
11/07/2000US6143921 Method for producing vinyl acetate monomer from ethane or ethylene oxidation
11/07/2000US6143920 Chloroacetic acid ester is reacted with an alkali metal methoxide to give the methoxyacetic acid ester
11/07/2000US6143918 Reacting a mixture of a 4,6-dibenzoylresorcinol and a para-aldehyde with a secondary amine catalyst and a carboxylic acid solvent and reacting the methylene carboxylate compound formed in step with an alcohol or a carboxylic acid
11/07/2000US6143914 Method and catalyst system for producing aromatic carbonates
11/07/2000US6143913 Carbonylating aromatic hydroxy compounds by contacting at least one aromatic hydroxy compound with oxygen and carbon monoxide in presence of a carbonylation catalyst system including an inorgaic co-catalyst containing zinc
11/07/2000US6143787 Heterocyclic or aromatic oxoacids
11/07/2000US6143198 Liquid crystalline compounds having exo-methylene site and liquid crystal compositions comprising the same
11/07/2000CA2189054C Photodegradable polyesters
11/07/2000CA2103298C Novel carbonate compounds, non-aqueous electrolytic solutions and batteries comprising non-aqueous electrolytic solutions
11/03/2000CA2307078A1 Mint and/or fruit flavor compositions
11/02/2000WO2000065002A1 Non-symmetric, partially fluorinated lubricant additives
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064854A1 Conjugated fatty acid esters
11/02/2000WO2000064853A2 Method of separating dimethyl carbonate and methanol
11/02/2000WO2000064851A1 Acrylate monomer preparation using alkali metal alkoxides as ester interchange catalysts and bromide salt polymerization inhibitors
11/02/2000WO2000064583A1 Metal catalysts and methods for making and using same
11/02/2000WO2000064555A2 Solvent extraction process
11/02/2000WO2000046235B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
11/02/2000EP1048647A1 N-Chlorocarbonyl-carbamate derivative and its use in the preparation of arthropodicidal oxadiazines
11/02/2000EP1048643A1 Process for the preparation of chiral epoxides
11/02/2000EP1047660A1 Esters with musky odor and their use in perfumery
11/02/2000EP1047659A1 A process for making high purity fatty acid lower alkyl esters
11/02/2000EP1047658A1 Method for producing alkoxylated dimer fatty acids
11/02/2000EP1047657A2 Dry emollient compositions
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
11/02/2000EP1047455A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging
11/02/2000EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000DE19919153A1 One-stage production of liquid crystal monomers containing acryloyl groups, useful for producing birefringent 3-dimensional networks, comprises reacting mesogenic alcohol with 3-chloropropionic ester
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371169A1 Acrylate monomer preparation using alkali metal alkoxides as ester interchange catalysts and bromide salt polymerization inhibitors
11/02/2000CA2370894A1 Solvent extraction process
11/01/2000CN1271721A Process for pressure separation of mathanol and dimethyl carbonate azeotrope
11/01/2000CN1271720A Organic anti reflection paint and its preparation
11/01/2000CN1058032C Liquid stabilizer composition for halogeno polymer
11/01/2000CN1057995C Substituted ortho-ethenylphenylacetic acid derivatives
10/2000
10/31/2000US6140529 Synthesis of optically active cyclohexylphenylglycolate esters
10/31/2000US6140439 Polymers of cyclopentene
10/31/2000US6140366 Anticonvulsant therapy for central nervous system disorders, e.g., epilepsy, huntington's chorea, cerebral ischemia, parkinson's disease, tardive dyskinesia, antispasmodic and psychotic disorders; antidepressant, anxiolytic agents
10/31/2000US6140360 Antifungal agent
10/31/2000US6140358 Substituted phenyl keto enols as pesticides and herbicides
10/31/2000US6140310 Phosphorous prodrugs
10/31/2000US6140274 Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production
10/31/2000US6139773 Cyclohexane derivatives, and liquid-crystalline medium
10/31/2000US6139771 Mesogenic materials with anomalous birefringence dispersion and high second order susceptibility (X.sup.(2)).